2 Reasons to Like JPM and 1 to Stay Skeptical
Is now still a good time to buy JPM? Or are investors being too optimistic? Find out in our full research report, it's free.
Tracing its roots back to 1799 when its earliest predecessor was founded by Aaron Burr, JPMorgan Chase (NYSE:JPM) is a leading financial services company offering investment banking, consumer banking, commercial banking, and asset management services globally.
Markets consistently prioritize net interest income growth over fee-based revenue, recognizing its superior quality and recurring nature compared to the more unpredictable non-interest income streams.
JPMorgan Chase's net interest income has grown at a 15% annualized rate over the last four years, better than the broader bank industry. Its growth was driven by both an increase in its outstanding loans and net interest margin, which represents how much a bank earns in relation to its outstanding loan book.
Analyzing the long-term change in earnings per share (EPS) shows whether a company's incremental sales were profitable – for example, revenue could be inflated through excessive spending on advertising and promotions.
JPMorgan Chase's EPS grew at an astounding 11.9% compounded annual growth rate over the last five years, higher than its 9.7% annualized revenue growth. This tells us the company became more profitable on a per-share basis as it expanded.
Topline growth is certainly important, but the overall profitability of this growth matters for the bottom line. For banks, we look at efficiency ratio, which is non-interest expense (salaries, rent, IT, marketing, excluding interest paid out to depositors) as a percentage of total revenue.
Markets understand that a bank's expense base depends on its revenue mix and what mostly drives share price performance is the change in this ratio, rather than its absolute value. It's somewhat counterintuitive, but a lower efficiency ratio is better.
For the next 12 months, Wall Street expects JPMorgan Chase to become less profitable as it anticipates an efficiency ratio of 54.6% compared to 50% over the past year.
JPMorgan Chase's merits more than compensate for its flaws, and with its shares topping the market in recent months, the stock trades at 2.3× forward P/B (or $292.13 per share). Is now a good time to buy? See for yourself in our comprehensive research report, it's free.
Donald Trump's victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs.
While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
Evercore ISI Maintains a Buy on Enovis Corporation (ENOV) With a $46 PT
Enovis Corporation (NYSE:ENOV) is one of the best undervalued medical device stocks to buy now. In a report released on July 8, Vijay Kumar from Evercore ISI maintained a Buy rating on Enovis Corporation (NYSE:ENOV) and set a price target of $46.00. A patient recieving cold therapy treatment using the company's products. The company reported continued commercial momentum in fiscal Q1 2025 results, with net sales for the quarter reaching $559 million and reported an 8% growth on a reported basis and 9% rise on a comparable basis from the same quarter last year. Reconstructive sales for the quarter rose 11% year-over-year on a reported basis. Enovis Corporation's (NYSE:ENOV) fiscal Q1 2025 results show a rebound in growth in Recon, net sales for which grew 11% on a reported and comparable basis. The company also showed accelerating momentum in new product introductions and continued execution in P&R, reflecting a 5% growth on a reported basis and 7% on a comparable growth basis. Enovis Corporation (NYSE:ENOV) is a medical technology growth company that develops clinically differentiated solutions to transform workflows and generate better patient outcomes. The company operates through the Prevention & Recovery and Reconstructive segments. While we acknowledge the potential of ENOV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
3 minutes ago
- Yahoo
Trump's Turnberry faces logistical hurdles for British Open return
PORTRUSH, Northern Ireland (AP) — President Donald Trump is not getting a British Open to the Turnberry course he owns in the near future, an issue the R&A's new chief executive said Wednesday was more about transportation than politics. Turnberry is regarded as the most beautiful of the links on the Open rotation, set along the Ayrshire coast in Scotland across from the Ailsa Craig. It last hosted the Open in 2009, before Trump bought the resort. Mark Darbon, who took over at the R&A this year from Martin Slumbers, said Turnberry had not been taken off the list of potential British Open sites, but transportation and other issues had to be addressed. 'I think we've been extremely clear on our position in respect of Turnberry. We love the golf course but we've got some big logistical challenges there,' he said. 'You see the scale of their setup here and we've got some work to do on the road, rail and accommodation infrastructure around Turnberry.' Darbon said the R&A met with Eric Trump and other leaders of Trump Golf a few months ago and the talks had been constructive. 'I think they understand clearly where we're coming from. We talked through some of the challenges that we have so we've got a good dialogue with them,' he said. Slumbers had previously said the R&A would not be going to Turnberry until it was comfortable the topic would be about golf and not the owner. Turnberry has only hosted the British Open four times, first in 1977 with the famous 'Duel in the Sun' when Tom Watson beat Jack Nicklaus. But the Open is getting bigger, and the roads are limited getting to Turnberry. There has been speculation Trump, whose golf courses have never hosted a men's major, might ask the British government to intercede in getting the Open back to Turnberry. 'We have an ongoing dialogue with the UK government given that we're a major event that creates significant value into the UK economy,' Darbon said. "We've spoken to them specifically about Turnberry and I think they've made it clear that the decision around where we take our championship rests with us. 'I would find it difficult to predict whether there will be any discussion on The Open if the President is making a visit here.' Turnberry is not the only Scottish links being ignored by the R&A. Muirfield, located along the Firth of Forth east of Edinburgh, is reputed to be the purest of links courses. Its first Open was in 1892, and there have been 15 others, most recently in 2013 won by Phil Mickelson. Only St. Andrews has hosted more Opens than Muirfield. But it has not been back there since 2013 as the R&A has been geared toward taking golf's oldest championship to courses that can hold big crowds. It is expected 278,000 spectators will be at Royal Portrush this week, the second-largest behind St. Andrews. The last Open at Muirfield had 142,000 spectators. The Open will be at Royal Birkdale next year, and then St. Andrews in 2027. The site for 2028 has not been announced. Muirfield has never gone more than 11 years — except for interruptions from World War I and World War II — between Opens. 'We love the golf course at Muirfield. We're in a discussion with the venue right now,' Darbon said. "There's some things that we need to evolve at Muirfield — the practice ground in particular is a challenge for us with a modern Open and there's some work we need to do with the venue to facilitate some of the infrastructure that we require. 'But it's a good dialogue and we'd love to be back there in the future.' ___ AP golf:
Yahoo
3 minutes ago
- Yahoo
Progressive profit more than doubles on strong personal insurance growth
(Reuters) -Progressive Corp reported second-quarter profit that more than doubled on Wednesday, boosted by robust performance in its personal lines insurance business, sending its shares up 1.5%. Insurance spending remained resilient during the quarter, as businesses and individuals continued spending on policies to protect against risks in a tough macroeconomic environment, despite rising premiums. Insurance companies were also helped by a solid U.S. job growth. The company had 36.1 million personal insurance policies in force, 16% higher than last year. Net premiums written rose 12% to $20.08 billion in the quarter and its combined ratio improved to 86.2% from 91.9% year-on-year. A ratio below 100% indicates the insurer earned more in premiums than it paid out in claims. Net income of the insurer came in at $3.18 billion, or $5.40 per share, in the three months ended June 30, compared with $1.46 billion, or $2.48 per share, a year ago. The Mayfield Village, Ohio-based company's shares have gained nearly 1% in 2025, as of last close, compared to a 6.2% rise in the benchmark S&P 500 index. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data